A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers
| Status: | Completed |
|---|---|
| Conditions: | Cancer, Cancer, Smoking Cessation, Tobacco Consumers |
| Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 105 |
| Updated: | 1/19/2019 |
| Start Date: | May 2014 |
| End Date: | May 2016 |
Efficacy and Impact of a Comprehensive Smoking Cessation Intervention During Radiation for Upper Aerodigestive Cancers
Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and
neck) and negatively impacts survival and other outcomes, but many patients have difficulty
quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far
have had limited success. This is a pilot randomized controlled trial designed to determine
if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates
for cancer patients who smoke.
neck) and negatively impacts survival and other outcomes, but many patients have difficulty
quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far
have had limited success. This is a pilot randomized controlled trial designed to determine
if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates
for cancer patients who smoke.
Inclusion Criteria:
- New diagnosis of head and neck or thoracic (including lung) cancer
- Undergoing radiation at Johns Hopkins Radiation Oncology for 5 or more weeks
- English-speaking and able to provide informed consent
- Smoked any cigarettes in previous 14 days
Exclusion Criteria:
- Palliative radiation
- Undergoing stereotactic radiosurgery
- Pregnant or breastfeeding
We found this trial at
1
site
Click here to add this to my saved trials
